Medulloblastoma is a rare brain malignant lesion, reported more in children with less prevalence among adults and rarely seen during pregnancy. The diagnosis of Medulloblastoma is a challenging clinical situation in pregnancy as surgery; radiotherapy and chemotherapy are the choices of management.
Introduction
Medulloblastoma is an embryonic tumor more prevalent in children than adults [1] . The tumor is highly aggressive but it is sensitive to radiation and chemotherapy [2] . Early diagnosis and surgical removal of the lesion is the key for its management.
Medulloblastomas are the most common malignant brain tumor of childhood and occur exclusively in the cerebellum. Medulloblastoma accounts for about 20% of the primary CNS tumors with a peak incidence between 5 -9 years and 70% of them presenting before the age of 20 years. A slight surge may seen during 20 -24 age but it is rare after 40 years of age [1] .
Males displayed higher incidence rates relative to females (males: 0.16 vs. females: 0.12), except in patients < 1 year-old [3] .
The signs and symptoms at presentation are due to raised intracranial pressure, cerebellar dysfunction and progression over few weeks to months.
MRI usually shows a contrast enhancing midline or paramedian cerebellar mass; about 30% of them will have disseminated tumor through subarachnoid space at presentation. Open Journal of Obstetrics and Gynecology Medulloblastoma rarely metastasize outside of the nervous system at diagnosis, and therefore systemic staging is not required at the time of diagnosis. The World Health Organization classification of brain tumors divides Medulloblastoma based upon histopathologic criteria into several variants, including classic, desmoplastic/nodular, desmoplastic with extensive nodularity, large cell, or anaplastic. Patients with large cell or anaplastic variants have a significantly poor prognosis. The main stay of therapy involves measures to reduce the raised intracranial pressure and specific tumor guided therapy-utilizing surgery, radiation therapy to the tumor area and craniospinal axis plus systemic chemotherapy [4] .
We report this case to identify the clinical presentations, investigation and management of Medulloblastoma during pregnancy at Latifa Hospital, DHA, Dubai, UAE. (Table 1) .
Case Report
MRI was done and followed by a multidisciplinary team decision including the Neurosurgeon, Obstetrician, and Internal medicine specialist based on the MRI findings, the neurosurgeon decided to operate immediately. The patient T. Gergawi et al. and her family were involved in the decision-making in depth counseling with details of the surgery and the risks were explained to them ( Figure 1 She tolerated the chemotherapy with some pancytopenia and gastrointestinal symptoms. The agents used were Cisplatin, CCNU (Lomustine) and Vincristine.
Local Radiation therapy was done at the site of excised tumor.
She had regular follow up over two years every 3 months with neuro-imaging no signs of relapse or residual tumor. She is stable with no complaint and normal MRI (Figure 4 ).
Discussion
Medulloblastomas have an embryonal origin, etiology and pathogenesis is not completely understood. It develops from immature or primitive cells [1] .
In the present case, the patient had a prior history of vomiting in pregnancy, of cases [6] . Microscopic evaluation of the lesion is the mainstay for establishing a confirmative diagnosis [7] . Immunohistochemistry can be used to confirm the diagnosis. Various markers like Synaptophysin, neuron-specific enolase, MAP-2, and class-III beta tubulin are found to be immunoreactive in cases of medulloblastomas [8] . and the numerically designated group 3 and group 4. Both the histologic and molecular subgroups have prognostic and therapeutic value [9] .
Once the diagnosis of Medulloblastoma is confirmed the tumor mass should be removed surgically as soon as possible. At times the tumor grows involving the brainstem making its total removal difficult. In such cases the surgery helps to remove as much lesion as possible. This is followed by craniospinal irradiation and chemotherapy [10] . A regular follow up MRI should be done to assess the early evidence of recurrence.
Termination of pregnancy after adequate preparation for the preterm delivery is crucial in case management which was done successfully aiming timed induction of chemo-radiation therapy which is the curable treatment for Medulloblastoma.
Close post treatment follows up and evaluation is part of the care journey to the curable stage.
Conclusion
Medulloblastoma is an embryonic tumor of childhood with less prevalence in adult hood and even lesser in females. Imaging is the modality of diagnosis. Microscopic evaluation of the lesion is the mainstay for establishing a confirmative diagnosis. Surgery and chemo-radiation therapy is option of treatment. Close post treatment follows up and evaluation is part of the care journey to the curable stage.
